ADRB2 and Airway obstruction: Thus, these two mechanisms impact a relevant β2-AR physiologic function, by acting as attenuators of the acute response, and represent specific interfaces where adjunct therapy or biased ligands may improve β2-AR agonist treatment of obstructive lung disease.